Landmark legislation in Italy: Provisions for the treatment of rare diseases and for the support of research and production of orphan drugs
FDA approves first drug to improve growth in children with most common form of Dwarfism
NICE creates new menu of treatment options for those suffering from depression
NICE’s Highly Specialised Technologies (HST) Programme offers a vital route for bringing ultra-rar...
NICE has introduced important appraisal reforms for 2025 that will directly impact manufacturers pre...
Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.